美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

BlackRock 2037 Municipal Target Term

25.56

-0.1900-0.74%

成交量：3,141

成交額：8.03萬

市值：1.57億

市盈率：39.32

高：25.56

開：25.56

低：25.56

收：25.75

52周最高：27.96

52周最低：23.96

股本：614.77萬

流通股本：614.77萬

量比：0.60

換手率：0.05%

股息：1.13

股息率：4.40%

每股收益(TTM):0.6500

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞公告

BioMarin ENPP1缺乏症三期臨床試驗折戟，BMN 401未達臨床獲益終點

环球市场播报

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BMN/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BMN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMN\",,,,,undefined,":{"symbol":"BMN","market":"US","secType":"STK","nameCN":"BlackRock 2037 Municipal Target Term","latestPrice":25.56,"timestamp":1782404519222,"preClose":25.75,"halted":0,"volume":3141,"delay":0,"changeRate":-0.007378640776699079,"floatShares":6147653,"shares":6147653,"eps":0.65,"marketStatus":"交易中","change":-0.19,"latestTime":"06-25 12:39:40 EDT","open":25.56,"high":25.56,"low":25.56,"amount":80346.522438,"amplitude":0,"askPrice":26.4,"askSize":100,"bidPrice":24.99,"bidSize":100,"shortable":3,"etf":0,"ttmEps":0.65,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1782417600000},"marketStatusCode":2,"adr":0,"listingDate":1666843200000,"exchange":"NYSE","adjPreClose":25.75,"dividendRate":0.044026,"postHourTrading":{"tag":"盘后","latestPrice":25.75,"preClose":25.75,"latestTime":"16:10 EDT","volume":15,"amount":387.77,"timestamp":1782331805114,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.6041},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMN\",,,,,undefined,":{"symbol":"BMN","floatShares":6147653,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.6041,"shares":6147653,"dividePrice":1.1253,"high":25.56,"amplitude":0,"preClose":25.75,"low":25.56,"week52Low":23.96,"pbRate":"--","week52High":27.96,"institutionHeld":0,"latestPrice":25.56,"eps":0.65,"divideRate":0.044026,"volume":3141,"delay":0,"ttmEps":0.65,"open":25.56,"prevYearClose":26.18,"prevWeekClose":26.1099,"prevMonthClose":25.85,"prevQuarterClose":25.94,"fiveDayClose":25.575,"twentyDayClose":25.66,"sixtyDayClose":26.1204},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BMN\",params:#limit:5,,,undefined,":[{"date":"2026-09-15","symbol":"BMN","amount":0.09375,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-15","defaultRemindTime":1789479000000,"name":"BlackRock 2037 Municipal Target Term","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-10-01","payableDate":"2026-09-15","currency":"USD","dateTimestamp":1789444800000,"payDate":"2026-10-01"},{"date":"2026-08-14","symbol":"BMN","amount":0.09375,"announcedDate":"2026-06-05","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-08-14","defaultRemindTime":1786714200000,"name":"BlackRock 2037 Municipal Target Term","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-01","payableDate":"2026-08-14","currency":"USD","dateTimestamp":1786680000000,"payDate":"2026-09-01"},{"date":"2026-07-15","symbol":"BMN","amount":0.09375,"announcedDate":"2026-06-05","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-07-15","defaultRemindTime":1784122200000,"name":"BlackRock 2037 Municipal Target Term","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-08-03","payableDate":"2026-07-15","currency":"USD","dateTimestamp":1784088000000,"payDate":"2026-08-03"},{"date":"2026-06-15","symbol":"BMN","amount":0.09375,"announcedDate":"2026-02-27","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"BlackRock 2037 Municipal Target Term","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-01","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-07-01"},{"date":"2026-05-15","symbol":"BMN","amount":0.09375,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-05-15","defaultRemindTime":1778851800000,"name":"BlackRock 2037 Municipal Target Term","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-01","payableDate":"2026-05-15","currency":"USD","dateTimestamp":1778817600000,"payDate":"2026-06-01"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BMN\",market:\"US\",,,undefined,":[{"executeDate":"2023-01-12","recordDate":"2023-01-13","paymentDate":"2023-02-01","value":0.09375,"currency":"USD"},{"executeDate":"2023-02-14","recordDate":"2023-02-15","paymentDate":"2023-03-01","value":0.09375,"currency":"USD"},{"executeDate":"2023-03-14","recordDate":"2023-03-15","paymentDate":"2023-04-03","value":0.09375,"currency":"USD"},{"executeDate":"2023-04-13","recordDate":"2023-04-14","paymentDate":"2023-05-01","value":0.09375,"currency":"USD"},{"executeDate":"2023-05-12","recordDate":"2023-05-15","paymentDate":"2023-06-01","value":0.09375,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BMN\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BMN\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2636077610","title":"BioMarin ENPP1缺乏症三期臨床試驗折戟，BMN 401未達臨床獲益終點","url":"https://stock-news.laohu8.com/highlight/detail?id=2636077610","media":"环球市场播报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636077610?lang=zh_tw&edition=fundamental","pubTime":"2026-05-18 23:45","pubTimestamp":1779119100,"startTime":"0","endTime":"0","summary":"　　BioMarin Pharmaceutical Inc．公布了针对1至12岁ENPP1缺乏症儿童的关键性III期ENERGY 3试验结果。BMN 401总体耐受性良好，未报告新的安全信号。　　ENPP1缺乏症是一种由ENPP1基因变异引起的罕见遗传病，可导致血管、软组织和骨骼进行性损伤。BMN 401是一种皮下注射的潜在“first-in-class”酶替代疗法，旨在纠正ENPP1酶缺乏。ENERGY 3试验共纳入27名患儿，已于2025年1月完成入组。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-18/doc-inhyivuf7960961.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BMN"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}]}}